Health Ministry Confirms Malaysian Man Tests Positive for Mpox What You Need to Know

Health Ministry Confirms Malaysian Man Tests Positive for Mpox: What You Need to Know

By Minul Islam Rony

Advertisements

New Mpox Case Detected in Sarawak

Health Ministry Confirms Malaysian Man Tests Positive for Mpox What You Need to Know
Health Ministry Confirms Malaysian Man Tests Positive for Mpox What You Need to Know

KUCHING, Sept 17: A new case of monkeypox (Mpox) has been confirmed in Malaysia, as announced by the Health Ministry today. The case involves a local male who tested positive for the Mpox clade 2 variant, a less severe form of the disease. This marks the latest development in the ongoing health monitoring efforts across the nation.

Patient’s Condition and Health Status

Datuk Dr Muhammad Radzi Abu Hassan, the Health Director-General, revealed that the patient began showing symptoms on September 11. The symptoms included fever, sore throat, and cough, with a rash appearing a day later. Importantly, the patient had not traveled abroad in the 21 days preceding the onset of symptoms.

Dr Muhammad Radzi assured that the patient has been isolated and is currently in stable condition. “We are closely monitoring the situation, and all contacts of the patient have been traced. Their health status will be continuously monitored following the stringent standard operating procedures (SOPs) in place,” he stated.

Health Ministry’s Response and Current Situation

The Ministry of Health (MOH) has been proactive in its response to the Mpox situation. Following the World Health Organisation’s (WHO) declaration of Mpox as a public health emergency of international concern on August 16, 2024, the MOH activated the Mpox Operations Room at the National Crisis Preparedness and Response Centre (CPRC).

Dr Muhammad Radzi emphasized the importance of these measures, stating, “The CPRC is actively monitoring the Mpox situation and coordinating the necessary preparedness and response measures to ensure public safety.”

Advertisements

Tracking and Monitoring Efforts

Since July 26, 2023, Malaysia has recorded a total of 10 Mpox cases, all of which involve the clade 2 variant. The MOH’s diligent tracking and monitoring have been crucial in managing and containing the spread of the virus.

Dr Muhammad Radzi reassured the public that the Ministry is committed to maintaining high standards of health and safety. “Our efforts are focused on ensuring that all necessary steps are taken to prevent further spread and to protect the health of Malaysians,” he added.

What Is Mpox?

Mpox, previously known as monkeypox, is a viral disease that can cause symptoms similar to smallpox. The clade 2 variant is known for being less severe compared to other strains. It is characterized by fever, rash, and sometimes respiratory symptoms. While Mpox can be concerning, the clade 2 variant typically results in a milder illness.

How Mpox Spreads

Mpox can be transmitted through direct contact with bodily fluids, skin lesions, or contaminated surfaces. Close contact with infected individuals or animals can also facilitate the spread of the virus. Given the current case, health authorities are emphasizing the importance of following SOPs to prevent further transmission.

Preventive Measures and Public Advice

The MOH continues to advise the public to adhere to basic hygiene practices, such as regular handwashing, avoiding close contact with suspected cases, and promptly seeking medical attention if symptoms arise. By following these guidelines, individuals can help mitigate the risk of Mpox spread.

Conclusion

The confirmation of this Mpox case in Sarawak highlights the ongoing need for vigilance and adherence to health guidelines. The Ministry of Health remains committed to managing the situation with transparency and efficiency. As the nation navigates through this health challenge, staying informed and following preventive measures will be key in ensuring public safety.

Advertisements

Share This Article
Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *